Structural basis of allosteric and synergistic activation of AMPK by furan-2-phosphonic derivative C2 binding
AMPK regulates the metabolism and so drugs that activate AMPK might have potential for the treatment of metabolic disease. Here, the authors report the structure of AMPK bound to an activating compound, revealing two binding sites and indicating that dual therapy might be a good drug strategy.
Guardado en:
Autores principales: | Christopher G. Langendorf, Kevin R. W. Ngoei, John W. Scott, Naomi X. Y. Ling, Sam M. A. Issa, Michael A. Gorman, Michael W. Parker, Kei Sakamoto, Jonathan S. Oakhill, Bruce E. Kemp |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/750524f5495343399d0ec23522953a11 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The autophagy initiator ULK1 sensitizes AMPK to allosteric drugs
por: Toby A. Dite, et al.
Publicado: (2017) -
CRYSTAL STRUCTURES OF TWO PHOSPHONATE SALTS: MONOCYCLOHEXYLAMMONIUM HYDROGEN PHOSPHONATE AND MONOCYCLOHEXYLAMMONIUM PHENYL PHOSPHONATE
por: MODOU SARR, et al.
Publicado: (2020) -
The predominance of nucleotidyl activation in bacterial phosphonate biosynthesis
por: Kyle Rice, et al.
Publicado: (2019) -
Synergistic effects of polyphenols and methylxanthines with Leucine on AMPK/Sirtuin-mediated metabolism in muscle cells and adipocytes.
por: Antje Bruckbauer, et al.
Publicado: (2014) -
Cellular Bioenergetics and AMPK and TORC1 Signalling in Blood Lymphoblasts Are Biomarkers of Clinical Status in FMR1 Premutation Carriers
por: Danuta Z. Loesch, et al.
Publicado: (2021)